Amylopectinosis in fetal and neonatal Quarter Horses.
Three Quarter Horses, a stillborn filly (horse No. 1), a female fetus aborted at approximately 6 months of gestation (horse No. 2), and a 1-month-old colt that had been weak at birth (horse No. 3), had myopathy characterized histologically by large spherical or ovoid inclusions in skeletal and cardiac myofibers. Smaller inclusions were also found in brain and spinal cord and in some cells of all other tissues examined. These inclusions were basophilic, red-purple after staining with periodic acid-Schiff (both before and after digestion with diastase), and moderately dark blue after staining with toluidine blue. The inclusions did not react when stained with Congo red. Staining with iodine ranged from pale blue to black. Their ultrastructural appearance varied from amorphous to somewhat filamentous. On the basis of staining characteristics and diastase resistance, we concluded that these inclusions contained amylopectin. A distinctly different kind of inclusion material was also present in skeletal muscle and tongue of horse Nos. 1 and 3. These inclusions were crystalline with a sharply defined ultrastructural periodicity. The crystals were eosinophilic and very dark blue when stained with toluidine blue but did not stain with iodine. Crystals sometimes occurred freely within the myofibers but more often were encased by deposits of amylopectin. This combination of histologic and ultrastructural features characterizes a previously unreported storage disease in fetal and neonatal Quarter Horses, with findings similar to those of glycogen storage disease type IV. We speculate that a severe inherited loss of glycogen brancher enzyme activity may be responsible for these findings. The relation of amylopectinosis to the death of the foals is unknown.
Render
J A
JA
Veterinary Medical Center, College of Veterinary Medicine, Michigan State University, East Lansing 48824, USA. render@ahdlms.cvm.msu.edu
Common
R S
RS
Kennedy
F A
FA
Jones
M Z
MZ
Fyfe
J C
JC
D000687:Amylopectin / Q000737:chemistry; D000818:Animals; D000831:Animals, Newborn; D004396:Coloring Agents / Q000737:chemistry; D003224:Congo Red / Q000737:chemistry; D005260:Female; D005315:Fetal Diseases / Q000196:embryology / Q000235:genetics / Q000473:pathology / Q000662:veterinary*; D006011:Glycogen Storage Disease Type IV / Q000196:embryology / Q000235:genetics / Q000473:pathology / Q000662:veterinary*; D006734:Horse Diseases / Q000196:embryology / Q000235:genetics / Q000473:pathology*; D006736:Horses; D002479:Inclusion Bodies / Q000473:pathology / Q000648:ultrastructure; D007455:Iodine / Q000737:chemistry; D008297:Male; D008854:Microscopy, Electron / Q000662:veterinary; D018482:Muscle, Skeletal / Q000196:embryology / Q000473:pathology / Q000648:ultrastructure; D010503:Periodic Acid-Schiff Reaction / Q000662:veterinary
D004396:Coloring Agents; D003224:Congo Red; D000687:Amylopectin; D007455:Iodine